Drug Shortage Report for SANDOZ IRBESARTAN HCT

Last updated on 2017-05-08 History
Report ID 2887
Drug Identification Number 02337444
Brand name SANDOZ IRBESARTAN HCT
Common or Proper name IRBESARTAN HYDROCHLOROTHIAZIDE
Company Name SANDOZ CANADA INCORPORATED
Active Ingredient(s) HYDROCHLOROTHIAZIDE IRBESARTAN
Strength(s) 25MG 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-03-14
Estimated end date 2017-04-28
Actual end date 2017-05-05
Shortage status Resolved
Updated date 2017-05-08
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2017-05-08 French Compare
v3 2017-05-08 English Compare
v2 2017-03-15 French Compare
v1 2017-03-15 English Compare